Intravitreal Lower- Dose (20 mu g) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds

---

Atıf İçin Kopyala

Tuncer S., Balci O., Tanyildiz B., Kebudi R., Shields C. L.

OPHTHALMIC SURGERY LASERS & IMAGING RETINA, cilt.46, sa.9, ss.942-948, 2015 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 46 Sayı: 9
• Basım Tarihi: 2015
• Doi Numarası: 10.3928/23258160-20151008-07
• Dergi Adı: OPHTHALMIC SURGERY LASERS & IMAGING RETINA
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.942-948
• İstanbul Üniversitesi Adresli: Evet

Özet

BACKGROUND AND OBJECTIVE: The major cause of failure in the management of retinoblastoma is the persistence/recurrence of vitreous seeds (VS). This study reports the efficacy and complications of standard lower-dose (20 mu g) intravitreal melphalan for VS.